-
FDA highlights new tech to monitor trials
01.09.2011The FDA is encouraging drug developers to turn to new technology to help them monitor clinical trial work without resorting to frequent site visits
прочети -
New R & D culture at GSK forces a challenging showdown
01.09.2011Researchers at GlaxoSmithKline face the dragon's den when it comes to gaining a financial commitment for their projects.
прочети -
NuPathe shares in meltdown after FDA rejects migraine patch app
31.08.2011The FDA has handed NuPathe a complete response letter detailing demands for new information on its experimental migraine patch
прочети -
Coral could hold key to sunscreen pill
31.08.2011Scientists hope to harness coral's natural defence against the sun's harmful ultraviolet rays to make a sunscreen pill for humans.
прочети -
Opticians 'should offer blood sugar checks'
31.08.2011Opticians should offer blood sugar checks alongside eye tests to help spot patients with undiagnosed diabetes, experts propose.
прочети -
FDA Approves Pfizer Lung-Cancer Drug
28.08.2011The U.S. Food and Drug Administration approved a Pfizer Inc. drug that shrinks tumors in lung-cancer patients with a rare genetic abnormality, the latest molecularly targeted therapy to win a rapid approval from the agency.
прочети -
Study: Cancer trial participation less than 1%
28.08.2011As conventional wisdom dictates, in order to solve a problem, one must first define it. Low enrollment in cancer drug trials has been a problem for developers, but a new study shows just how dire the situation really is. Less than 1% of cancer patients in one survey enrolled in a clinical trial, according to the study.
прочети -
Vitamin A pills could save thousands of children
28.08.2011Giving vitamin A supplements to children under the age of five in developing countries could save 600,000 lives a year, researchers claim.
прочети -
Psoriasis linked to stroke risk
28.08.2011People with psoriasis have nearly three times the normal risk of stroke and abnormal heart rhythm, according to scientists in Denmark.
прочети -
Scientists find weakness in deadly Ebola virus
28.08.2011Reuters - A protein that helps transport cholesterol inside cells may be a key to developing drugs to treat Ebola, a rare but lethal virus for which there are no known treatments, U.S. researchers said.
прочети
Търсене в сайта
Лекарствен справочник
http://sommons.co/out?zoneId=2647810-2647961
